Solventum (SOLV) Cash from Financing Activities (2023 - 2026)
Solventum's (SOLV) quarterly Cash from Financing Activities came in at -$50.0 million in Q1 2026, up 64.03% YoY from -$30.5 million in Q1 2025, and up 56.52% on a QoQ basis from -$115.0 million in Q4 2025.
Solventum (SOLV) Cash from Financing Activities (2023 - 2026) Analysis & Trends
Solventum (SOLV) has 4 years of Cash from Financing Activities data on file, last reported at -$50.0 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 64.03% year-over-year to -$50.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.0 billion (down 252.91% YoY) and the FY2025 annual result came in at -$3.1 billion, down 1173.75% from the prior year.
- Cash from Financing Activities improved to -$50.0 million in Q1 2026, from -$115.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $462.0 million in Q1 2024 to a low of -$2.7 billion in Q3 2025.
- A 4-year average of -$376.8 million and a median of -$202.0 million in 2024 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 200.0% — and 2025, when it slumped 1233.17%.
- Tracing SOLV's Cash from Financing Activities over 4 years: stood at -$306.0 million in 2023, then surged by 66.01% to -$104.0 million in 2024, then fell by 10.58% to -$115.0 million in 2025, then surged by 56.52% to -$50.0 million in 2026.
- The last three Cash from Financing Activities figures came in at -$50.0 million (Q1 2026), -$115.0 million (Q4 2025), and -$2.7 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | -67.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -300.00 Mn |
| Jun 30, 2026 | -300.00 Mn |
| Mar 31, 2026 | -50.00 Mn |
| Mar 31, 2026 | -50.00 Mn |
| Dec 31, 2025 | -115.00 Mn |
| Dec 31, 2025 | -115.00 Mn |
| Sep 30, 2025 | -2.69 Bn |
| Sep 30, 2025 | -2.69 Bn |
| Jun 30, 2025 | -110.00 Mn |
| Jun 30, 2025 | -110.00 Mn |
| Mar 31, 2025 | -139.00 Mn |
| Mar 31, 2025 | -139.00 Mn |
| Dec 31, 2024 | -104.00 Mn |
| Dec 31, 2024 | -104.00 Mn |
| Sep 30, 2024 | -202.00 Mn |
| Sep 30, 2024 | -202.00 Mn |
| Jun 30, 2024 | -396.00 Mn |
| Jun 30, 2024 | -396.00 Mn |
| Mar 31, 2024 | 462.00 Mn |
| Mar 31, 2024 | 462.00 Mn |